Tag: biosimilars

Understand the key differences between biosimilars and generics, including FDA approval pathways, interchangeability rules, and strategies for provider education to improve patient care.

Discover why some brand-name drugs lack generic alternatives due to patent thickets, complex biologics, and anti-competitive practices. Learn how these barriers impact drug prices and what patients can do.

Specialty pharmacy handles high-cost, complex medications where generics and biosimilars are changing the game. Learn how pharmacists manage substitution, patient concerns, PBM pressures, and the growing role of biosimilars in chronic disease care.